주메뉴 바로가기
본문 바로가기
메인으로 이동
For Tomorrow, LigaChemBio
About Us
Message from CEO
Overview
History
VISION 2030
Leadership
R&D
Research Area
Core Technology
Partnerships
Pipeline
ADC
Small molecule
Investors
Stock
Disclosure
Corporate Presentations
Analyst Coverage
Press Release
Notice
Financial Information
ESG
ESG Overview
Environment
Social
Governance
Data Room
Careers
Our Culture
Process
Current Job Opportunities
Language
Korean
English
Menu
Investors
home
:
Investors
:
Disclosure
Disclosure
Disclosure chart
As of 2025-01-17 13:40:30
Information provided: KOSCOM DATA
Material Management Information related to Judgment of Investment(Study Results)(메티실린 내성 황색포도상구균 (MRSA) 균혈증 치료제 델파졸리드(LCB01-0371)의 제 2a상 임상시험 결과)
2024-12-18
Organization of Investor Relations Event
2024-11-22
Material Management Information related to Judgment of Investment(LCB97 관련 마일스톤 기술료 수령)
2024-11-18
Release from designation as Investment Alert Issue & Prior notice on Re-designation
2024-10-25
Additional Listing(주식매수선택권행사)
2024-10-24
Decision on Entering into Trust Contract for Acquisition of Treasury Stock
2024-10-14
Designation as Investment Alert Issue
2024-10-10
Material Management Information related to Judgment of Investment(항체-약물 복합체(ADC) 멀티타겟 대상 공동연구 및 원천기술 기술이전계약 체결)
2024-10-10
view more